West Pharmaceutical Services, Inc. (WST)
Growth
Revenue 5Y13.23%
Revenue 3Y18.14%
EPS 5Y35.52%
EPS 3Y47.34%
Dividend 5Y7.20%
Dividend 3Y6.67%
Capital Efficiency
ROIC27.56%
ROE26.39%
ROA19.01%
ROTA19.12%
Capital Structure
Market Cap19.79B
EV19.36B
Cash729M
Current Ratio3.80
Debt/Equity0.26
Net Debt/EBITDA-0.49
WST
Income Statement
Select a metric from the list below to chart it
Dec '85
Dec '92
Dec '99
Dec '06
Dec '13
Dec '20
| Income Statement | Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,368.4 | 1,421.4 | 1,399.8 | 1,509.1 | 1,599.1 | 1,717.4 | 1,839.9 | 2,146.9 | 2,831.6 | 2,909.0 | |
| Revenue % Chg. | 8.1% | 3.9% | -1.5% | 7.8% | 6.0% | 7.4% | 7.1% | 16.7% | 31.9% | 8.5% | |
| Cost of Revenue | 933.7 | 973.6 | 944.0 | 1,008.0 | 1,086.5 | 1,172.0 | 1,234.2 | 1,379.1 | 1,655.8 | 1,734.3 | |
| Cost of Revenue % Chg. | 6.3% | 4.3% | -3.0% | 6.8% | 7.8% | 7.9% | 5.3% | 11.7% | 20.1% | 8.8% | |
| Gross Profit | 434.7 | 447.8 | 455.8 | 501.1 | 512.6 | 545.4 | 605.7 | 767.8 | 1,175.8 | 1,174.7 | |
| Gross Profit % Chg. | 12.1% | 3.0% | 1.8% | 9.9% | 2.3% | 6.4% | 11.1% | 26.8% | 53.1% | 8.1% | |
| Gross Profit Margin | 31.8% | 31.5% | 32.6% | 33.2% | 32.1% | 31.8% | 32.9% | 35.8% | 41.5% | 40.4% | |
| Gross Profit Margin % Chg. | 3.8% | -0.8% | 3.4% | 2.0% | -3.5% | -0.9% | 3.7% | 8.6% | 16.1% | -0.3% | |
| R&D Expenses | 37.9 | 38.5 | 34.1 | 36.8 | 39.1 | 40.3 | 38.9 | 46.9 | 52.8 | 56.3 | |
| R&D Expenses % Chg. | 14.2% | 1.6% | -11.4% | 7.9% | 6.3% | 3.1% | -3.5% | 20.6% | 12.6% | 8.3% | |
| Selling, General, & Admin Expenses | 234.9 | 228.7 | 243.9 | 237.7 | 242.6 | 262.9 | 272.7 | 302.0 | 362.8 | 329.2 | |
| Selling, General, & Admin Expenses % Chg. | 7.7% | -2.6% | 6.6% | -2.5% | 2.1% | 8.4% | 3.7% | 10.7% | 20.1% | -3.5% | |
| Other Expenses | - | -1.6 | -1.5 | -1.6 | -6.7 | -5.7 | -10.5 | - | - | - | |
| Other Expenses % Chg. | - | - | 6.3% | 6.7% | 318.8% | 14.9% | 84.2% | - | - | - | |
| Operating Income | 162.4 | 182.0 | 128.6 | 196.8 | 228.9 | 240.3 | 296.6 | 406.9 | 752.3 | 788.3 | |
| Operating Income % Chg. | 20.2% | 12.1% | -29.3% | 53.0% | 16.3% | 5.0% | 23.4% | 37.2% | 84.9% | 15.2% | |
| Operating Income Margin | 11.9% | 12.8% | 9.2% | 13.0% | 14.3% | 14.0% | 16.1% | 19.0% | 26.6% | 27.1% | |
| Operating Income Margin % Chg. | 11.2% | 7.9% | -28.3% | 41.9% | 9.8% | -2.3% | 15.2% | 17.6% | 40.2% | 6.2% | |
| Total Other Income/Expenses Net | -15.3 | -13.0 | -12.5 | -7.0 | -6.5 | 0.4 | -4.8 | -5.6 | -3.4 | -55.2 | |
| Total Other Income/Expenses Net % Chg. | 42.3% | 15.0% | 3.8% | 44.0% | 7.1% | - | - | 16.7% | 39.3% | 2300.0% | |
| Income Before Tax | 147.1 | 169.0 | 116.1 | 189.8 | 222.4 | 240.7 | 291.8 | 401.3 | 748.9 | 733.1 | |
| Income Before Tax % Chg. | 35.5% | 14.9% | -31.3% | 63.5% | 17.2% | 8.2% | 21.2% | 37.5% | 86.6% | 7.5% | |
| Income Before Tax Margin | 10.7% | 11.9% | 8.3% | 12.6% | 13.9% | 14.0% | 15.9% | 18.7% | 26.4% | 25.2% | |
| Income Before Tax Margin % Chg. | 25.4% | 10.6% | -30.2% | 51.6% | 10.6% | 0.8% | 13.2% | 17.9% | 41.5% | -0.9% | |
| Income Tax Expense | 40.2 | 47.2 | 26.3 | 54.4 | 80.9 | 41.4 | 59.0 | 72.5 | 107.2 | 120.0 | |
| Income Tax Expense % Chg. | 22.9% | 17.4% | -44.3% | 106.8% | 48.7% | -48.8% | 42.5% | 22.9% | 47.9% | 28.5% | |
| Net Income | 112.3 | 127.1 | 95.6 | 143.6 | 150.7 | 206.9 | 241.7 | 346.2 | 661.8 | 630.6 | |
| Net Income % Chg. | 39.2% | 13.2% | -24.8% | 50.2% | 4.9% | 37.3% | 16.8% | 43.2% | 91.2% | 3.0% | |
| Net Income Margin | 8.2% | 8.9% | 6.8% | 9.5% | 9.4% | 12.0% | 13.1% | 16.1% | 23.4% | 21.7% | |
| Net Income Margin % Chg. | 28.8% | 9.0% | -23.6% | 39.3% | -1.0% | 27.8% | 9.0% | 22.8% | 44.9% | -5.1% | |
| Weighted Avg. Shares Out | 69.6 | 70.9 | 72.0 | 73.3 | 73.9 | 73.9 | 74.0 | 73.9 | 73.9 | 74.5 | |
| Weighted Avg. Shares Out % Chg. | 2.4% | 1.9% | 1.6% | 1.8% | 0.8% | - | 0.1% | -0.1% | - | 0.6% | |
| EPS | 1.6 | 1.8 | 1.3 | 2.0 | 2.0 | 2.8 | 3.3 | 4.7 | 9.0 | 8.5 | |
| EPS % Chg. | 35.9% | 11.2% | -25.7% | 47.4% | 4.1% | 37.3% | 16.8% | 43.1% | 91.5% | 2.3% | |
| Weighted Avg. Shares Out Dil | 71.4 | 72.8 | 73.8 | 75.0 | 75.8 | 75.4 | 75.4 | 75.8 | 75.8 | 76.1 | |
| Weighted Avg. Shares Out Dil % Chg. | -0.6% | 2.0% | 1.4% | 1.6% | 1.1% | -0.5% | - | 0.5% | - | 0.2% | |
| EPS Diluted | 1.6 | 1.8 | 1.3 | 1.9 | 2.0 | 2.7 | 3.2 | 4.6 | 8.7 | 8.3 | |
| EPS Diluted % Chg. | 36.5% | 11.5% | -25.7% | 46.9% | 4.2% | 37.7% | 17.2% | 42.4% | 91.0% | 2.6% | |
| Interest Income | 1.9 | 3.5 | 1.6 | 1.1 | 1.3 | 2.1 | 3.8 | 1.4 | 1.0 | 2.5 | |
| Interest Income % Chg. | 5.6% | 84.2% | -54.3% | -31.3% | 18.2% | 61.5% | 81.0% | -63.2% | -28.6% | 177.8% | |
| Interest Expense | 17.0 | 16.5 | 14.1 | 8.1 | 7.8 | 8.4 | 8.5 | 8.2 | 8.2 | 9.2 | |
| Interest Expense % Chg. | 1.8% | -2.9% | -14.5% | -42.6% | -3.7% | 7.7% | 1.2% | -3.5% | - | 19.5% | |
| EBIT | 132.0 | 156.0 | 103.6 | 182.8 | 215.9 | 234.4 | 287.1 | 394.5 | 741.7 | 726.4 | |
| EBIT % Chg. | 40.9% | 18.2% | -33.6% | 76.4% | 18.1% | 8.6% | 22.5% | 37.4% | 88.0% | 7.6% | |
| EBIT Margin | 9.6% | 11.0% | 7.4% | 12.1% | 13.5% | 13.6% | 15.6% | 18.4% | 26.2% | 25.0% | |
| EBIT Margin % Chg. | 30.4% | 13.8% | -32.6% | 63.7% | 11.5% | 1.1% | 14.3% | 17.8% | 42.5% | -0.9% | |
| Depreciation & Amortization | 85.2 | 90.0 | 89.9 | 90.7 | 96.7 | 104.4 | 103.4 | 109.1 | 122.3 | 123.9 | |
| Depreciation & Amortization % Chg. | 10.8% | 5.6% | -0.1% | 0.9% | 6.6% | 8.0% | -1.0% | 5.5% | 12.1% | 6.4% | |
| EBITDA | 217.2 | 246.0 | 193.5 | 273.5 | 312.6 | 338.8 | 390.5 | 503.6 | 864.0 | 850.3 | |
| EBITDA % Chg. | 27.3% | 13.3% | -21.3% | 41.3% | 14.3% | 8.4% | 15.3% | 29.0% | 71.6% | 7.4% | |
| EBITDA Margin | 15.9% | 17.3% | 13.8% | 18.1% | 19.5% | 19.7% | 21.2% | 23.5% | 30.5% | 29.2% | |
| EBITDA Margin % Chg. | 17.8% | 9.0% | -20.1% | 31.1% | 7.9% | 0.9% | 7.6% | 10.5% | 30.1% | -1.0% |